Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

794.19
-13.5200-1.67%
Post-market: 797.002.81+0.35%19:44 EDT
Volume:488.31K
Turnover:387.71M
Market Cap:81.77B
PE:19.64
High:809.40
Open:809.40
Low:789.08
Close:807.71
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.74
T/O Rate:0.49%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.58
PE(LYR):19.15

Loading ...

Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

JW Cayman Therapeutics FY26 H1 IFRS Loss Narrows 81.14% to RMB 50.4 Million; Revenue Rises 4.7% to RMB 111.4 Million

Reuters
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25

Regeneron Selects Veeva Vault CRM for Global Rollout

Reuters
·
Aug 25

Regeneron Pharmaceuticals (REGN) Wins Pasatru Approval, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 22

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims

TIPRANKS
·
Aug 21

Sweden's Medivir Q2 Turnover Falls

Reuters
·
Aug 20

Telix Swings to H1 FY26 Net Profit of US$38 Million; Revenue Rises 22% to Us$477 Million

Reuters
·
Aug 20

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Reuters
·
Aug 20

Regeneron Announces Investor Conference Presentations

GlobeNewswire
·
Aug 20

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live
·
Aug 20

US FDA Approves Regeneron's Rare Bone Disorder Drug

Reuters
·
Aug 20

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Reuters
·
Aug 20

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS
·
Aug 20